Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 179

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study

Sung, Lillian, Hayden, Jill, Greenberg, Mark L., Koren, Gideon, Feldman, Brian M., Tomlinson, George A. · 2005 · Journal of Clinical Epidemiology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jclinepi.2004.08.010

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 45

  1. Lewis, 1993, An introduction to the Bayesian analysis of clinical trials, Ann Emerg Med, 22, 1328, 10.1016/S0196-0644(05)80119-2 · DOI
  2. Berry, 1993, A case for Bayesianism in clinical trials, Stat Med, 12, 1377, 10.1002/sim.4780121504 · DOI · Paper page
  3. Kadane, 1995, Prime time for Bayes, Control Clin Trials, 16, 313, 10.1016/0197-2456(95)00072-0 · DOI
  4. Spiegelhalter, 2000, Bayesian methods in health technology assessment: a review, Health Technol Assess, 4, 1, 10.3310/hta4380 · DOI · Paper page
  5. Auranen, 1999, A hierarchical Bayesian model to predict the duration of immunity to Haemophilus influenzae type b, Biometrics, 55, 1306, 10.1111/j.0006-341X.1999.01306.x · DOI
  6. Austin, 2002, A comparison of Bayesian methods for profiling hospital performance, Med Decis Making, 22, 163, 10.1177/0272989X0202200213 · DOI
  7. Austin, 2001, A comparison of a Bayesian vs. a frequentist method for profiling hospital performance, J Eval Clin Pract, 7, 35, 10.1046/j.1365-2753.2001.00261.x · doi:10.1046/j.1365-2753.2001.00261.x
  8. Bergamaschi, 2001, Predicting secondary progression in relapsing-remitting multiple sclerosis: a Bayesian analysis, J Neurol Sci, 189, 13, 10.1016/S0022-510X(01)00572-X · DOI
  9. Brennan, 2002, Recent trends and future directions for lung cancer mortality in Europe, Br J Cancer, 87, 43, 10.1038/sj.bjc.6600352 · DOI
  10. Brophy, 1999, Medical decision making in the choice of a thrombolytic agent for acute myocardial infarction. Quebec Acute Coronary Care Working Group, Med Decis Making, 19, 411, 10.1177/0272989X9901900409 · DOI
  11. Burroughs, 1999, Significance testing of clinical data using virus dynamics models with a Markov chain Monte Carlo method: application to emergence of lamivudine-resistant hepatitis B virus, Proc R Soc Lond B Biol Sci, 266, 2359, 10.1098/rspb.1999.0932 · doi:10.1098/rspb.1999.0932
  12. Cancre, 2000, Bayesian analysis of an epidemiologic model of Plasmodium falciparum malaria infection in Ndiop, Senegal, Am J Epidemiol, 152, 760, 10.1093/aje/152.8.760 · DOI
  13. Chouquet, 1999, Timing of human immunodeficiency virus type 1 (HIV-1) transmission from mother to child: Bayesian estimation using a mixture, Stat Med, 18, 815, 10.1002/(SICI)1097-0258(19990415)18:7<815::AID-SIM74>3.0.CO;2-G · doi:10.1002/(sici)1097-0258(19990415)18:7<815::aid-sim74>3.0.co;2-g
  14. Couris, 2002, Method of correction to assess the number of hospitalized incident breast cancer cases based on claims databases, J Clin Epidemiol, 55, 386, 10.1016/S0895-4356(01)00487-5 · doi:10.1016/s0895-4356(01)00487-5
  15. Estey, 2002, Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinoside, Blood, 99, 4343, 10.1182/blood.V99.12.4343 · DOI
  16. Freedman, 1992, Application of Bayesian statistics to decision making during a clinical trial, Stat Med, 11, 23, 10.1002/sim.4780110105 · DOI
  17. Gausche, 2000, Effect of out-of-hospital pediatric endotracheal intubation on survival and neurological outcome: a controlled clinical trial, JAMA, 283, 783, 10.1001/jama.283.6.783 · DOI · Paper page
  18. Gomez, 2000, Risk of HIV infection as a function of the duration of intravenous drug use: A non-parametric Bayesian approach, Stat Med, 19, 2641, 10.1002/1097-0258(20001015)19:19<2641::AID-SIM527>3.0.CO;2-P · doi:10.1002/1097-0258(20001015)19:19<2641::aid-sim527>3.0.co;2-p
  19. Hamilton, 2001, Estimating treatment effects in randomized clinical trials with non-compliance: the impact of maternal smoking on birthweight, Health Econ, 10, 399, 10.1002/hec.629 · DOI
  20. Hammack, 2002, Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy, Pain, 98, 195, 10.1016/S0304-3959(02)00047-7 · DOI · Paper page
  21. Holley, 2001, Ethical dilemmas in a randomized trial of asthma treatment: can Bayesian statistical analysis explain the results?, Acad Emerg Med, 8, 1128, 10.1111/j.1553-2712.2001.tb01128.x · doi:10.1111/j.1553-2712.2001.tb01128.x
  22. Hopman, 2002, Is there regional variation in the SF-36 scores of Canadian adults?, Can J Public Health, 93, 233, 10.1007/BF03405008 · doi:10.1007/bf03405008
  23. Kiuchi, 1995, Change points in the series of T4 counts prior to AIDS, Biometrics, 51, 236, 10.2307/2533329 · DOI
  24. Knorr-Held, 2001, Projections of lung cancer mortality in West Germany: a case study in Bayesian prediction, Biostatistics, 2, 109, 10.1093/biostatistics/2.1.109 · DOI
  25. Launoy, 1997, Colorectal cancer mass-screening: Estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time, Int J Cancer, 73, 220, 10.1002/(SICI)1097-0215(19971009)73:2<220::AID-IJC10>3.0.CO;2-J · doi:10.1002/(sici)1097-0215(19971009)73:2<220::aid-ijc10>3.0.co;2-j
  26. Luo, 2001, Two-locus modeling of asthma in a Hutterite pedigree via Markov chain Monte Carlo, Genet Epidemiol, 21, S24, 10.1002/gepi.2001.21.s1.s24 · doi:10.1002/gepi.2001.21.s1.s24
  27. Machado-Santelli, 1994, Prediction of relapse in patients with breast cancer by DNA cytometry, Anal Cell Pathol, 7, 321
  28. Mar, 1998, Ambulatory blood pressure monitoring and diagnostic errors in hypertension: a Bayesian approach, Med Decis Making, 18, 429, 10.1177/0272989X9801800411 · doi:10.1177/0272989x9801800411
  29. McNeil, 1996, Statistical analysis of zidovudine (AZT) effect on CD4 cell counts in HIV disease, Stat Med, 15, 75, 10.1002/(SICI)1097-0258(19960115)15:1<75::AID-SIM142>3.0.CO;2-8 · doi:10.1002/(sici)1097-0258(19960115)15:1<75::aid-sim142>3.0.co;2-8
  30. McNeil, 1997, Bayes estimates for immunological progression rates in HIV disease, Stat Med, 16, 2555, 10.1002/(SICI)1097-0258(19971130)16:22<2555::AID-SIM690>3.0.CO;2-Y · doi:10.1002/(sici)1097-0258(19971130)16:22<2555::aid-sim690>3.0.co;2-y
  31. Menard, 2001, Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables, J Clin Oncol, 19, 329, 10.1200/JCO.2001.19.2.329 · DOI
  32. Nakisa, 2001, Functionally equivalent ages and hearing levels of children with cochlear implants measured with pre-recorded stimuli, Br J Audiol, 35, 183, 10.1080/00305364.2001.11745236 · doi:10.1080/00305364.2001.11745236
  33. Neuenschwander, 2000, Trends in the prevalence of infection with Mycobacterium tuberculosis in Korea from 1965 to 1995: an analysis of seven surveys by mixture models, Int J Tuberc Lung Dis, 4, 719
  34. Nielsen, 1999, Novel tests for marker-disease association using the Collaborative Study on the Genetics of Alcoholism data, Genet Epidemiol, 17, S265, 10.1002/gepi.1370170745 · DOI
  35. Normand, 1997, Statistical methods for profiling providers of medical care: issues and applications, J Am Stat Assoc, 92, 803, 10.1080/01621459.1997.10474036 · DOI · Paper page
  36. Pan, 2000, Antibiotics and return visits for respiratory illness: a comparison of pooled versus hierarchical statistical methods, Am J Med Sci, 319, 360, 10.1097/00000441-200006000-00003 · doi:10.1097/00000441-200006000-00003
  37. Raab, 1993, Bayesian analysis of binary data from an audit of cervical smears, Stat Med, 12, 2179, 10.1002/sim.4780122304 · DOI
  38. Ramachandran, 2001, Retrospective exposure assessment using Bayesian methods, Ann Occup Hyg, 45, 651, 10.1093/annhyg/45.8.651 · DOI
  39. Vail, 2001, Prospective application of Bayesian monitoring and analysis in an “open” randomized clinical trial, Stat Med, 20, 3777, 10.1002/sim.1171 · DOI
  40. Vey, 1999, Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: results of a randomized phase I/II study, Invest New Drugs, 17, 89, 10.1023/A:1006271618635 · doi:10.1023/a:1006271618635
  41. Vounatsou, 2000, Apparent tolerance of Plasmodium falciparum in infants in a highly endemic area, Parasitology, 120, 1, 10.1017/S0031182099005211 · DOI
  42. Weiss, 2001, Bayesian monitoring of a phase 2 chemoprevention trial in high-risk cohorts for prostate cancer, Urology, 57, 220, 10.1016/S0090-4295(00)00979-1 · DOI
  43. Zwahlen, 2000, HIV testing and retesting for men and women in Switzerland, Eur J Epidemiol, 16, 123, 10.1023/A:1007638823567 · doi:10.1023/a:1007638823567
  44. Altman, 2002, How statistical expertise is used in medical research, JAMA, 287, 2817, 10.1001/jama.287.21.2817 · DOI
  45. Brooks, 1998, Convergence assessment techniques for Markov chain Monte Carlo, Stat Comput, 8, 319, 10.1023/A:1008820505350 · DOI · Paper page

Cited by

See all 179

Metadata

Authors
Sung, L., Hayden, J., Greenberg, M. L., Koren, G., Feldman, B. M., & Tomlinson, G. A.
Venue
Journal of Clinical Epidemiology
Publisher
Elsevier BV
Published
2005-03
Volume
58
Issue
3
Pages
261-268
ISSN
0895-4356 (ISSN-L)
OpenAlex
W2142460408
Cited by
179
References
4
FWCI
2.95
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study. https://app.cochat.ai/papers/10.1016/j.jclinepi.2004.08.010
The paper
Sung, L., Hayden, J., Greenberg, M. L., Koren, G., Feldman, B. M., & Tomlinson, G. A. (2005). Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study. Journal of Clinical Epidemiology. https://doi.org/10.1016/j.jclinepi.2004.08.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.